Contract Liabilities and Other Disclosures, as restated |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Contract Liabilities And Other Disclosures As Restated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Contract Liabilities and Other Disclosures, as restated | 7. Contract Liabilities and Other Disclosures, as restated
The following table summarizes contract related balances:
Revenue recognized that was included in the deferred income balance at the beginning of the period amounted to $2.4 million and $4.2 million for the six months ended June 30, 2023 and 2022, respectively.
For the periods ended June 30, 2023 and 2022 respectively, there was no significant amounts of revenue recognized as a result of changes in contract transaction price related to performance obligations that were satisfied in the respective prior periods.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||